Key facts
- This page summarizes Vineet Agarwal's Form 4 filing for Korro Bio, Inc. (KRRO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Nov 2024, 19:40.
Vineet Agarwal - 11 Nov 2024 Form 4 Insider Report for Korro Bio, Inc. (KRRO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- KRRO
- Reported as of
- 11 Nov 2024
- Net transaction value
- -$46,656
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2024, 19:40:46 UTC
- Prior SEC filing
- 18 Oct 2024
- Next SEC filing
- 05 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jeffrey Cerio, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vineet Agarwal filed Form 4 for Korro Bio, Inc. (KRRO) on 12 Nov 2024.
Change
- Previous filing in this sequence was filed on 18 Oct 2024.
- Current net transaction value: -$46,656.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRRO
transaction
Common Stock
Options Exercise
- Transaction value
- $9,344
- Shares
- +800
- Change %
- Price
- $11.68
- Shares after
- 800
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
KRRO
transaction
Common Stock
Sale
- Transaction value
- $56,000
- Shares
- -800
- Change %
- -100%
- Price
- $70.00
- Shares after
- 0
- Date
- 11 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KRRO
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -800
- Change %
- -2.5%
- Price
- $0.000000
- Shares after
- 30,807
- Date
- 11 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 800
- Exercise price
- $11.68
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
Footnote F2
The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
SEC remarks
Exhibit 24.1 - Power of Attorney